|1|AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? (19941898)
Rieber N.... Belohradsky B.H.
|2|Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies. (17806156)
Smith M.J.... Garrett R.H.
|3|Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome. (17892268)
MartA-nez-Cabot A.... Messeguer A.
|4|Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. (10606395)
Johnson K.L.... Naylor S.
|5|On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome. (9817085)
Williamson B.L.... Naylor S.
|6|Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome. (9076948)
Hitraya E.G.... Varga J.
|7|The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels. (8906286)
|8|1995 Bailey K. Ashford lecture. Public health lessons from two catastrophic epidemics: the toxic oil syndrome and the eosinophilia-myalgia syndrome. (8744866)
|9|1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro. (8624499)
Zangrilli J.G.... Varga J.
|10|Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. (8579979)
Kaufman L.D.... Krupp L.B.
|11|Eosinophilia-myalgia syndrome: a long-term follow-up study. (7660215)
Campbell D.S.... Silver R.M.
|12|P-31 magnetic resonance spectroscopy of skeletal muscle in the eosinophilia-myalgia syndrome: a preliminary study. (8035389)
Clauw D.J.... Rajan S.
|13|Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome. (7955801)
Flockhart D.A.... Woosley R.L.
|14|The eosinophilia-myalgia syndrome: lessons from Germany. (8015338)
Mayeno A.N.... Gleich G.J.
|15|Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome. (8184420)
Sidransky H.... Mayeno A.N.
|16|Eosinophilia myalgia syndrome: absence of immunoglobulin reactivity suggests a cellular rather than humoral mechanism. (7976226)
Villanova M.... Martin J.J.
|17|Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. (8015323)
Carr L.... Lehnert H.
|18|Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS). (8475503)
Kurihara N.... Wada O.
|19|Eosinophilia-myalgia syndrome and fasciitis with an active alveolitis. (8355447)
Chauhan D.... MENGEL C.E.
|20|Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report. (8266108)
Philen R.M.... Posada M.
|21|The eosinophilia-myalgia syndrome: current concepts and future directions. (1551286)
|22|Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1386918)
Keating J.P.... Viggiano J.
|23|Central nervous system involvement in the eosinophilia-myalgia syndrome. (1417516)
Lynn J.... Kissel J.T.
|24|A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome. (1732344)
Feldman S.R.... Maize J.C.
|25|Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome. (1504513)
Driskell W.J.... Hill R.H.
|26|Episodic angioedema with eosinophilia versus eosinophilia-myalgia syndrome. (1583248)
Kaufman L.E.... Kaplan A.P.
|27|Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome. (1534836)
Freimer M.L.... Kuncl R.W.
|28|Eosinophilia-myalgia syndrome: the aftermath. (1523446)
Sack K.E.... Criswell L.A.
|29|Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1929872)
Adachi J.... Tatsuno Y.
|30|Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome. (2068062)
DeSchryver-Kecskemeti K.... Sternberg E.M.
|31|Eosinophilia-myalgia syndrome: the Cleveland Clinic experience. (1934454)
|32|Eosinophilia-myalgia syndrome associated with L-tryptophan use. (1984598)
|33|L-tryptophan-induced eosinophilia-myalgia syndrome. (1829754)
Arnouts P.J.... Van Moer E.M.
|34|Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome. (2058857)
James T.N.... Kilbourne E.M.
|35|Unraveling the eosinophilia-myalgia syndrome. (1863082)
|36|Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group. (2001136)
Philen R.M.... Voorhees R.
|37|Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease. (2273104)
Kaufman L.D.... Gruber B.L.
|38|Dermal mucinosis in the eosinophilia-myalgia syndrome. (2241211)
Farmer K.L.... Jordan R.E.
|39|The eosinophilia-myalgia syndrome. (2339858) |1990|
|40|Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. (2164712)
Varga J.... Jimenez S.A.
|41|Eosinophilia-myalgia syndrome: unresolved questions. (2372919)
|42|Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. (2162498)
Smith B.E.... Dyck P.J.
|43|L-tryptophan induced eosinophilia-myalgia syndrome. (2273498)
Chartash E.K.... Furie R.A.
|44|Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome. (2166897) |1990|
|45|Eosinophilia-myalgia syndrome. Results of national surveillance. (2398610)
Swygert L.A.... Kilbourne E.M.
|46|The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. (2339856)
Dicker R.M.... Cunha B.A.
|47|Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States, as of January 9, 1990. (2104651) |1990|
|48|Eosinophilia-myalgia syndrome with myoclonic jerks. (2292676)
Korthals J.K.... Gieron-Korthals M.A.
|49|The eosinophilia-myalgia syndrome. (2139551) |1990|
|50|Eosinophilia-myalgia syndrome--New Mexico. (2509886) |1989|